Genetic profiling of Lyme disease could bring new therapeutic targets
Drug Discovery World
NOVEMBER 17, 2022
The study is the first to use transcriptomics as a blood test to measure RNA levels in patients with long-term Lyme disease. . As part of the study, RNA sequencing was conducted using blood samples from 152 patients with symptoms of post-treatment Lyme disease to measure their immune response. .
Let's personalize your content